Page last updated: 2024-11-12
rapalexin a
Description
rapalexin A: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 16102148 |
CHEMBL ID | 2253033 |
SCHEMBL ID | 19400912 |
MeSH ID | M0507990 |
Synonyms (6)
Synonym |
929083-72-7 |
CHEMBL2253033 |
rapalexin a |
3-isothiocyanato-4-methoxy-1h-indole |
DTXSID70582863 |
SCHEMBL19400912 |
Bioassays (3)
Assay ID | Title | Year | Journal | Article |
AID1092145 | Antifungal activity against Leptosphaeria maculans assessed as mycelial radial growth inhibition on potato dextrose agar at 0.50 mM relative to control | 2012 | Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
| The cruciferous phytoalexins rapalexin A, brussalexin A and erucalexin: chemistry and metabolism in Leptosphaeria maculans. |
AID1092143 | Antifungal activity against Leptosphaeria maculans assessed as mycelial radial growth inhibition on potato dextrose agar at 0.10 mM relative to control | 2012 | Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
| The cruciferous phytoalexins rapalexin A, brussalexin A and erucalexin: chemistry and metabolism in Leptosphaeria maculans. |
AID1092144 | Antifungal activity against Leptosphaeria maculans assessed as mycelial radial growth inhibition on potato dextrose agar at 0.20 mM relative to control | 2012 | Bioorganic & medicinal chemistry, Jul-01, Volume: 20, Issue:13
| The cruciferous phytoalexins rapalexin A, brussalexin A and erucalexin: chemistry and metabolism in Leptosphaeria maculans. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |